CTOs on the Move


 
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.my01.io
  • 400 Boul de Maisonneuve Ouest Suite 700
    Montréal, QC CAN H3A 1L4
  • Phone: 855.799.6901

Executives

Name Title Contact Details

Similar Companies

Amerinet

Through Total Spend Management solutions, Amerinet strategically partners with health care providers to improve operating margins by creating efficiencies, reducing costs and identifying new revenue s.

Perferx Optical Company Inc

Perferx Optical Company Inc is a Pittsfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiomend Inc

Cardiomend Inc is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vicarious Surgical

At Vicarious Surgical we are revolutionizing the field of surgical robotics. We seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. We have reimagined what is possible by building a human-like surgical robot and combining it with the world`s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.

PreXion

PreXion is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.